Related Experiment Video
Updated: Sep 10, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Expressing Vitreoscilla hemoglobin in Escherichia coli Nissle 1917 enhances its probiotic potential for alleviating
Yuqing Yang1, Fan Liu1, Dihao Zeng1
1State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China.
Abstract:
Ulcerative colitis causes chronic intestinal inflammation with a complex etiology and limited treatment options. Active probiotics are an effective way to treat gastrointestinal diseases, which often face challenges in surviving and colonizing the complex gastrointestinal environment. In this study, we investigated the potential of Escherichia coli Nissle 1917 with a cloned bacterial hemoglobin gene (EcN-VHb) in intestinal colonization and therapeutic efficacy for treating ulcerative colitis. The EcN-VHb strain demonstrated exceptional resistance to hypoxic and oxidative stress, endowing it with an advantageous edge in intestinal colonization in testing mice. EcN-VHb also modulated the gut microbiota and alleviated dextran sulfate sodium-induced colitis in mice, a model of ulcerative colitis. In comparison, the parent strain EcN relieved the colitis with reduced efficiency. This study provides a novel approach to enhance the stability and functionality of probiotics in hypoxic gut environments and offers a potentially new platform for developing other probiotic-based therapies.
Related Concept Videos
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Stringent Response in E. coli
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

